CURRENTLY ON AIR ⇒
  • Highlights of the Days Programmes
    Monday, 10:05 pm - 4:00 am
    [ - ]

feedback@radioislam.org.za

logo


((( Listen Live )))))
Radio Islam Logo


Zimbabwe Hails China over Vaccine Supplies

Zimbabwe’s presidential spokesman, George Charamba, said Zimbabwe is to receive a further 800 000 doses of the Covid-19 vaccine from China. He said that this indicated the “excellent relationship” between the two countries, as well as China’s willingness to give Zimbabwe “preferential treatment” amidst a global “stampede” for vaccines.

The BBC reports that Zimbabwe had purchased 600 000 doses of the vaccine from Chinese firm Sinopharm, while 200 000 were donated, bringing to 400 000 the total donated by the Chinese government. Zimbabwe’s vaccination programmed was launched last week, with Vice-President Constantino Chiwenga taking the first shot. Zimbabwe plans to inoculate about 10 million people, with the vaccines  expected to cover front-line workers, the elderly and people with chronic health conditions.

Zimbabwe is also expected to receive over a million doses under the World Health Organization’s Covax scheme. The scheme aims to make vaccines more accessible to poorer countries. The BBC reports that India has indicated that it, too, is to donate 75 000 doses to Zimbabwe.

Umm Muhammed Umar

 

ADVERTISE HERE

Prime Spot!!!

Contact:
advertisingadmin@radioislam.co.za 

Related Articles

Palestine Report

15 September 2025 | 13:15 CAT 3-minute read Israel’s Relentless Gaza Bombardment Leaves Islamic University in Ruins, Global Summit Yields Little Action Residents of Gaza City describe a night of terror as Israeli airstrikes intensified this week, targeting densely...

read more
The Debrief Report

The Debrief Report

15 September 2025 | 12:32 CAT 3-minute read Nepal’s Social Media Ban and Westbury’s Dry Taps: Fury at Failed Leadership Fuels Parallel Protests From the crowded streets of Kathmandu to the dry taps of Westbury, ordinary people are reaching a breaking point. Across...

read more

Subscribe to our Newsletter

0 Comments